NeoGenomics
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $209,254 | $201,656 | $186,672 | $190,170 |
Gross Profit | 96,588 | 91,878 | 80,864 | 75,711 |
EBITDA | 9,435 | 18,817 | -567 | 4,588 |
EBIT | -6,754 | 2,607 | -16,980 | -11,807 |
Net Income | -7,546 | 2,238 | -17,106 | -9,881 |
Net Change In Cash | 209,254 | 201,656 | 186,672 | 190,170 |
Free Cash Flow | -20,658 | 11,740 | -13,137 | -6,528 |
Cash | 139,281 | 145,539 | 146,143 | 159,618 |
Basic Shares | 128,587 | 130,831 | 129,166 | 128,648 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $727,332 | $660,566 | $591,643 | $509,728 |
Gross Profit | 282,541 | 290,100 | 244,604 | 187,896 |
EBITDA | -38,691 | -1,511 | -17,607 | -82,331 |
EBIT | -106,515 | -74,058 | -90,190 | -151,761 |
Net Income | -108,025 | -78,726 | -87,968 | -144,250 |
Net Change In Cash | 727,332 | 660,566 | 591,643 | 509,728 |
Cost of Revenue | -53,647 | |||
Free Cash Flow | -21,778 | -34,038 | -30,705 | -96,884 |
Cash | 159,618 | 367,012 | 342,488 | 263,180 |
Basic Shares | 128,101 | 126,658 | 125,502 | 124,217 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | $0.01 |
2026-06-30 | -$0.01 |
2026-03-31 | $0.01 |
2025-12-31 | $0.06 |